Literature DB >> 10614803

Efficacy of vitamin E compared with either simvastatin or atorvastatin in preventing the progression of atherosclerosis in homozygous familial hypercholesterolemia.

F J Raal1, G J Pilcher, M G Veller, M J Kotze, B I Joffe.   

Abstract

Over a 4-year period, antioxidant therapy (vitamin E) was compared with high-dose statin therapy in 15 patients with homozygous familial hypercholesterolemia. Carotid intima-media thickness, used as an in vivo assessment of atherosclerosis, progressed rapidly during the period of vitamin E therapy but regressed on statin therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10614803     DOI: 10.1016/s0002-9149(99)00570-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

Review 1.  Statins in children: what do we know and what do we need to do?

Authors:  D M Black
Journal:  Curr Atheroscler Rep       Date:  2001-01       Impact factor: 5.113

Review 2.  Benefits and risks of simvastatin in patients with familial hypercholesterolaemia.

Authors:  Pedro Mata; Rodrigo Alonso; Juan Badimón
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey.

Authors:  S Walzer; K Travers; S Rieder; E Erazo-Fischer; D Matusiewicz
Journal:  Clinicoecon Outcomes Res       Date:  2013-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.